Kian Behbakht

10PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersCancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 04, 2026
On the predictability of progression-free survival in ovarian cancer from NanoString gene expression data.

|Aug 13, 2025
Utilizing Serum-Derived Lipidomics with Protein Biomarkers and Machine Learning for Early Detection of Ovarian Cancer in the Symptomatic Population.

Brendan M Giles, Rachel Culp-Hill, Robert A Law

|Dec 03, 2024
Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival.

Fabian R Villagomez, Julie Lang, Daniel Nunez-Avellaneda

|Sep 16, 2024
Claudin-4 remodeling of nucleus-cell cycle crosstalk maintains ovarian tumor genome stability and drives resistance to genomic instability-inducing agents.

Fabian R Villagomez, Julie Lang, Daniel Nunez-Avellaneda

|Aug 13, 2024
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent Manner.

Lily L Nguyen, Zachary L Watson, Raquel Ortega

|Aug 08, 2024
The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma.

Lucy B Van Kleunen, Mansooreh Ahmadian, Miriam D Post

Pageof 2

Frequent Collaborators

10 joint publications

Benjamin G Bitler

5 joint publications

Elizabeth R Woodruff

4 joint publications

Tomomi M Yamamoto

4 joint publications

Kimberly R Jordan